Patients who were diagnosed early on in the study, or who received endocrine therapy or radical prostatectomy, exhibited a lower HR for mortality vs other patients with PC.
Stronger effect on prostate cancer-linked, all-cause mortality for those with prediagnostic use.
What every physician needs to know: Lung cancer symptoms usually arise from the direct effects of tumor on the lungs or contiguous structures by compression, obstruction, or invasion of other organs. However, another important form of clinical presentation is paraneoplastic syndromes. Paraneoplastic syndromes are defined as symptoms and signs distant to the primary tumor site…
Prostate Adenocarcinoma What every physician needs to know: Prostate adenocarcinoma is the most common non-cutaneous cancer and the second leading cause of cancer death in men in the US, with an annual incidence of over 200,000 cases per year and an annual mortality of over 30,000 deaths per year. Screening for prostate cancer (using digital…
Eosinophilic Fasciitis (Shulman Disease, Diffuse Fasciitis with Eosinophilia) Are You Confident of the Diagnosis? What you should be alert for in the history Patients with eosinophilic fasciitis (EF) typically give a history of progressive, symmetric skin thickening of the extremities. Some patients complain of rapidly progressive muscle weakness, with associated pain and stiffness of the…
Radical prostatectomy Yanhong Liu, M.D., Ph.D.; William R. Kimball, M.D., Ph.D.; Yandong Jiang M.D., Ph.D. What the Anesthesiologist Should Know before the Operative Procedure Different from simple prostatectomy, which is done mainly for the treatment of prostate enlargement (benign prostatic hyperplasia), radical prostatectomy is the treatment of choice for localized prostate cancer. As the fourth…
Statin use by men receiving androgen deprivation therapy for advanced PCa was associated with decreased risk of overall and cancer-specific mortality.
Researchers are promoting physician and patient awareness about the potential tie between depression and certain therapies.
Multiple studies have examined the possible association between cell phone usage and increased cancer risk, but study designs, potential biases, and interpretations of statistical outcomes leave conclusions uncertain.
Clifford Pukel, MD, discusses from an immunological standpoint the mysterious phenomenon of spontaneous regression.